WO2003008562A3 - Methods for detecting genes associated with bone properties, height, and/or body mass properties - Google Patents

Methods for detecting genes associated with bone properties, height, and/or body mass properties Download PDF

Info

Publication number
WO2003008562A3
WO2003008562A3 PCT/US2002/023293 US0223293W WO03008562A3 WO 2003008562 A3 WO2003008562 A3 WO 2003008562A3 US 0223293 W US0223293 W US 0223293W WO 03008562 A3 WO03008562 A3 WO 03008562A3
Authority
WO
WIPO (PCT)
Prior art keywords
bone
properties
subject
methods
polymorphism
Prior art date
Application number
PCT/US2002/023293
Other languages
French (fr)
Other versions
WO2003008562A2 (en
Inventor
Robert R Recker
Hong-Wen Deng
Original Assignee
Univ Creighton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Creighton filed Critical Univ Creighton
Priority to AU2002322584A priority Critical patent/AU2002322584A1/en
Publication of WO2003008562A2 publication Critical patent/WO2003008562A2/en
Publication of WO2003008562A3 publication Critical patent/WO2003008562A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Disclosed are methods for detecting the presence in a subject of a polymorphism linked to a gene associated with one or more bone properties, such as spine bone mineral density, hip bone mineral density, wrist bone mineral density, spine bone size, hip bone size, and wrist bone size. The method includes analyzing at least a portion of the subject's genome and detecting the presence of a polymorphism which is located in or near various specified regions of the subject's genome and which is linked to the gene associated with the bone property of interest. The presence of the polymorphism is indicative of the subject having or being susceptible to having aberrant bone properties. Also disclosed are methods for detecting the presence in a subject of a polymorphism linked to a gene associates with height or with one or more body mass properties, such as body mass index, percentage fat mass, fat mass, and lean mass. The methods can be used, for example, to screen for a subject's having or being susceptible to conditions such as osteoporosis and obesity.
PCT/US2002/023293 2001-07-20 2002-07-22 Methods for detecting genes associated with bone properties, height, and/or body mass properties WO2003008562A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002322584A AU2002322584A1 (en) 2001-07-20 2002-07-22 Methods for detecting genes associated with bone properties, height, and/or body mass properties

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30669001P 2001-07-20 2001-07-20
US60/306,690 2001-07-20
US33682901P 2001-10-26 2001-10-26
US60/336,829 2001-10-26

Publications (2)

Publication Number Publication Date
WO2003008562A2 WO2003008562A2 (en) 2003-01-30
WO2003008562A3 true WO2003008562A3 (en) 2003-05-22

Family

ID=26975295

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/023293 WO2003008562A2 (en) 2001-07-20 2002-07-22 Methods for detecting genes associated with bone properties, height, and/or body mass properties

Country Status (2)

Country Link
AU (1) AU2002322584A1 (en)
WO (1) WO2003008562A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7524664B2 (en) 2003-06-17 2009-04-28 California Institute Of Technology Regio- and enantioselective alkane hydroxylation with modified cytochrome P450
EP2415868A4 (en) * 2009-05-15 2012-11-28 Univ Tokyo Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
STINE C. ET AL.: "Vitamin D receptor polymorphisms and hip bone mineral density in baltimore women", JBMR, vol. 14, September 1999 (1999-09-01), pages S456, ABSTRACT NO. SU100, XP002959965 *

Also Published As

Publication number Publication date
AU2002322584A1 (en) 2003-03-03
WO2003008562A2 (en) 2003-01-30

Similar Documents

Publication Publication Date Title
EP1246114A3 (en) Methods for genomic analysis
FR2873015B1 (en) FASTENING IMPLANT FOR THE OSTEOSYNTHESIS OF FRAGMENTS OF A FIRST FRACTURE OR OSTEOTOMIZED METATARSIS IN ITS PROXIMAL PART AND CORRESPONDING OSTEOSYNTHESIS METHOD
EP2100614A3 (en) PDGFR-alpha antagonists for treatment of metastatic bone cancer
EP1436385A4 (en) Dna polymerases and mutants thereof
WO2002023483A3 (en) Technique for manipulating medical images
EP0986651A4 (en) Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
TR200003650T2 (en) ß2-adrenergic receptor agonists
WO2002041781A3 (en) Method and apparatus for analysis of blood vessel images
WO2002061659A3 (en) Computer-assisted means for assessing lifestyle risk factors
AU2002212188A1 (en) Method for determining the degree of methylation of defined cytosines in genomic DNA in the sequence context 5'-CPG-3'
EP2363477A3 (en) Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
WO1999052425A3 (en) Body composition analyzer with trend display
WO2005042036A3 (en) Facet triangle spinal fixation device and method of use
EP1578347A4 (en) Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
WO2005033333A3 (en) Methods and compositions for the diagnosis of cancer
ATE349551T1 (en) METHODS AND COMPOSITIONS FOR DETERMINING PERIOPERATIVE GENOME PROFILES
WO1999051727A3 (en) Human nucleic acid sequences of normal ovary tissue
WO2003008562A3 (en) Methods for detecting genes associated with bone properties, height, and/or body mass properties
WO2002016553A3 (en) Regulator gene and system useful for the diagnosis and therapy of osteoporosis
WO2002002000A3 (en) Methods of screening for alzheimer's disease
WO2003054166A3 (en) Nucleotide polymorphisms associated with osteoarthritis
WO2004018642A3 (en) Methods for detecting genes associated with bone properties and/or height
AU2002358580A1 (en) Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms
DE69434809D1 (en) BC200 RNA, SPECIFIED SAMPLES AND CORRESPONDING APPLICATIONS
FR2708614A1 (en) Nucleic acids which are markers for the genes for resistance to rice rust and genes for resistance to rice rust Pi-ta and Pi-ta<2> which are isolated by means of these markers

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP